← Back
Data updated: Mar 10, 2026
ADC Therapeutics SA
OncologyGastroenterology
ADC Therapeutics SA is a biotechnology company focused on Oncology, Gastroenterology.
2021
Since
1
Drugs
-
Trials
2
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 97%
1 drugs Phase 3: 1 Phase 2: 4 Phase 1: 14
Gastroenterology 3%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2021-04-23
- Latest
- 2026-02-20
- Applications
- 1